RA
Royce & Associates Portfolio holdings
AUM
$9.74B
1-Year Return
15.99%
This Quarter Return
+3.51%
1 Year Return
+15.99%
3 Year Return
+81.23%
5 Year Return
+192.6%
10 Year Return
+438.14%
AUM
$10.8B
AUM Growth
-$222M
(-2%)
Cap. Flow
-$311M
Cap. Flow
% of AUM
-2.88%
Top 10 Holdings %
Top 10 Hldgs %
9.23%
Holding
920
New
57
Increased
332
Reduced
337
Closed
91
Top Buys
| 1 |
FormFactor
FORM
|
+$17.9M |
| 2 |
LCI Industries
LCII
|
+$17.8M |
| 3 |
Quaker Houghton
KWR
|
+$17M |
| 4 |
AMERISAFE
AMSF
|
+$15.7M |
| 5 |
Advance Auto Parts
AAP
|
+$15.5M |
Top Sells
| 1 |
Ziff Davis
ZD
|
+$35M |
| 2 |
Applied Optoelectronics
AAOI
|
+$30.8M |
| 3 |
Coherent
COHR
|
+$29.6M |
| 4 |
First Citizens BancShares
FCNCA
|
+$28.3M |
| 5 |
IES Holdings
IESC
|
+$23.4M |
Sector Composition
| 1 | Industrials | 24.84% |
| 2 | Technology | 19.75% |
| 3 | Financials | 14.91% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Healthcare | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Kforce
KFRC
$574M
| $3.33M | 0.03% |
58,728
-122
| -0.2% | -$6.92K |
|
552
MaxCyte
MXCT
$152M
| $3.33M | 0.03% |
799,873
+475,949
| +147% | +$1.98M |
|
553
Ironwood Pharmaceuticals
IRWD
$184M
| $3.26M | 0.03% |
735,436
+72,502
| +11% | +$321K |
|
554
Fluence Energy
FLNC
$893M
| $3.26M | 0.03% |
+205,000
| New | +$3.26M |
|
555
Hovnanian Enterprises
HOV
$869M
| $3.24M | 0.03% |
24,200
| – | – |
|
556
Bright Horizons
BFAM
$6.59B
| $3.16M | 0.03% |
28,506
+4,300
| +18% | +$477K |
|
557
Unifirst Corp
UNF
$3.17B
| $3.15M | 0.03% |
18,430
| – | – |
|
|
ITCI
558
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.13M | 0.03% |
37,500
| – | – |
|
559
Axsome Therapeutics
AXSM
$6.26B
| $3.13M | 0.03% |
37,000
+14,500
| +64% | +$1.23M |
|
560
NextNav
NN
$2.23B
| $3.08M | 0.03% |
197,894
-208,000
| -51% | -$3.24M |
|
561
Donnelley Financial Solutions
DFIN
$1.56B
| $3.07M | 0.03% |
48,969
-47,659
| -49% | -$2.99M |
|
562
Cytek Biosciences
CTKB
$515M
| $3.06M | 0.03% |
470,819
+289,425
| +160% | +$1.88M |
|
563
Freeport-McMoran
FCX
$63.1B
| $3.05M | 0.03% |
80,000
| – | – |
|
564
Silicon Laboratories
SLAB
$4.46B
| $3.04M | 0.03% |
24,500
| – | – |
|
565
Viking Therapeutics
VKTX
$2.84B
| $3.03M | 0.03% |
75,261
+61,927
| +464% | +$2.49M |
|
566
TELA Bio
TELA
$63.8M
| $3.02M | 0.03% |
+1,000,064
| New | +$3.02M |
|
567
Jacobs Solutions
J
$17.2B
| $3.01M | 0.03% |
22,725
| – | – |
|
568
Stride
LRN
$7.16B
| $2.98M | 0.03% |
28,678
-90
| -0.3% | -$9.35K |
|
569
Bowman Consulting
BWMN
$698M
| $2.92M | 0.03% |
117,140
-53,565
| -31% | -$1.34M |
|
570
Radian Group
RDN
$4.71B
| $2.91M | 0.03% |
91,603
+7,914
| +9% | +$251K |
|
571
Zumiez
ZUMZ
$356M
| $2.89M | 0.03% |
150,837
-27,163
| -15% | -$521K |
|
572
Texas Roadhouse
TXRH
$11.2B
| $2.89M | 0.03% |
16,000
| – | – |
|
573
Aehr Test Systems
AEHR
$750M
| $2.86M | 0.03% |
171,765
| – | – |
|
574
Inogen
INGN
$228M
| $2.85M | 0.03% |
311,199
+259,308
| +500% | +$2.38M |
|
575
PROS Holdings
PRO
$751M
| $2.81M | 0.03% |
128,164
+81,500
| +175% | +$1.79M |
|